A comparison of omeprazole and placebo for bleeding peptic ulcer.
about
Proton pump inhibitor treatment for acute peptic ulcer bleedingProton pump inhibitor treatment for acute peptic ulcer bleedingNon-variceal upper gastrointestinal haemorrhage: guidelinesA comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcerProton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trialDrug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end pointsIntravenous omeprazole after endoscopic treatment of bleeding peptic ulcersA prospective study of aspirin use and the risk of gastrointestinal bleeding in menProton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics.A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding.How evidence-based are current guidelines for managing patients with peptic ulcer bleeding?Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots.Management of upper gastrointestinal haemorrhage.Proton-pump inhibitors for acute peptic ulcer bleeding.Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer.Upper endoscopy in patients with acute myocardial infarction and upper gastrointestinal bleeding: results of a decision analysisVariable use of endoscopic haemostasis in the management of bleeding peptic ulcersEvidence-based medicine and information mastery: application for acute gastrointestinal conditions.Prevention and treatment of gastrointestinal complications in patients on mechanical ventilation.The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.Comparison of oral and intravenous proton pump inhibitor on patients with high risk bleeding peptic ulcers: a prospective, randomized, controlled clinical trial.Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleedingSystematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia--a post hoc analysis from the Cochrane Collaboration.Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay--results from the Cochrane Collaboration.Current management of peptic ulcer bleeding.Review article: acid-related disease--what are the unmet clinical needs?Outcome of non-variceal acute upper gastrointestinal bleeding in relation to the time of endoscopy and the experience of the endoscopist: a two-year surveyPre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.Endoscopic management of non-variceal upper gastrointestinal haemorrhage.The evidence base of palliative medicine: is inpatient palliative medicine evidence-based?Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.Acid peptic diseases: pharmacological approach to treatment.Diagnosis and management of nonvariceal upper gastrointestinal bleeding.Modern management of acute non-variceal upper gastrointestinal bleeding.Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients.Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots.Pharmacological Treatment in Upper Gastrointestinal Bleeding.Is the era of intravenous proton pump inhibitors coming to an end in patients with bleeding peptic ulcers? Meta-analysis of the published literature.
P2860
Q24235528-B7253F4D-555E-4210-8AE9-47EC19208A69Q24244855-766E9332-1FAA-40E2-A296-84A877DA281EQ24685894-78AF6C92-3BD7-4520-8BEC-4AB2CDB33660Q25256848-965B66B9-3A79-49F8-8013-787BC0E3586CQ28196664-9D07B40C-23ED-4348-8B7D-90309F01BA87Q28346263-721CAF7B-7B9C-4015-A0BF-9CB9D6D120E0Q28361594-69531A45-F0AC-470C-9191-3537A1FC50BBQ28743884-D0BCA271-9E01-4894-9D39-D94C6F4A79FCQ33224563-B59F99A7-EEED-4FF9-AEB5-2D6AB8650459Q33692802-388BBD7D-5798-4224-9C9D-C15C58AD9CE8Q33772529-C015EECC-D96F-41D2-9B1B-CC170C6C5276Q33792368-56063088-FC22-43F4-B930-6C017301D14DQ33866733-D3CA19D2-28F3-4D2E-B9C0-C91648269447Q34095664-AFBDA39D-5B53-43E4-BEE9-D89FCA9F0F45Q34284276-E246E155-D283-422B-8613-2D9BFEBE2B7AQ34297884-95C0049D-1630-4571-8B0E-529F0E13A2A4Q34523442-6F07C649-E56D-4941-A49A-1601CD6815C4Q35024907-06E78BD9-6624-4A8F-B1BC-7D41134E37BAQ35514470-F6BD64EE-A433-4BD8-83CE-D8D55806702CQ35572504-3A8DF234-5C1A-40F8-9C5B-E031B934C79CQ35627636-764C8F00-3F66-4541-ADAC-CAF94896FE36Q35826352-8897204C-5477-4FFA-B709-C6E8D4AD1E3DQ36022469-048FDDC0-E38F-4ABB-9799-9692D2899F62Q36026166-9CE2215B-0CC6-4CAC-8537-9095BCA2443AQ36107901-2E4E3413-916D-4C15-8D67-B731E3C92397Q36223548-8EA8194D-0B4E-4C74-842C-51B2F72F5622Q36362419-2FB12776-5E87-4815-AB20-D30900D99027Q36478873-BA60E7F8-446A-42E2-9D98-1269B940B69EQ36496813-8164A38C-B783-4784-9A40-BD5A31E34F1CQ36609905-5FE6883D-63EE-4F8A-B730-5ECB43DA2FBAQ36771780-D86FD3E3-65DE-4634-9F8A-5A3AE3A428DDQ36974038-E4FC1C3C-E72C-4583-A963-E2A41EEEB784Q37173955-606A0D11-62F7-4751-91CB-ACA9C374F038Q37913063-B9A9410E-052B-4184-9955-0B95F5FA67DFQ37974466-D577D15F-637D-4B2A-9806-555929C2C860Q38127294-A63A125E-6B0E-4722-9DEC-CB9648B42DD2Q38399837-EA5077D8-4A60-4DE5-9186-197E302A2FB5Q38522353-1CA14D6D-47DB-4100-B1AC-F619557C1297Q38574508-DD63E291-6D2E-4D4E-9059-AAD26A755979Q38672590-8FF73745-4BC9-49E5-8D0D-DEB8D77A054F
P2860
A comparison of omeprazole and placebo for bleeding peptic ulcer.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
A comparison of omeprazole and placebo for bleeding peptic ulcer.
@en
A comparison of omeprazole and placebo for bleeding peptic ulcer.
@nl
type
label
A comparison of omeprazole and placebo for bleeding peptic ulcer.
@en
A comparison of omeprazole and placebo for bleeding peptic ulcer.
@nl
prefLabel
A comparison of omeprazole and placebo for bleeding peptic ulcer.
@en
A comparison of omeprazole and placebo for bleeding peptic ulcer.
@nl
P2093
P1476
A comparison of omeprazole and placebo for bleeding peptic ulcer.
@en
P2093
P304
P356
10.1056/NEJM199704103361503
P407
P577
1997-04-01T00:00:00Z